Covid-19 deaths increase ten-fold in three weeks, to reach 2,130
Deaths from the novel coronavirus have increased to 2,130, representing a ten-fold surge in three...
Read More...
Focus:
-
![Roche Tecentriq]()
Roche’s Tecentriq gets US priority review for lung cancer
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics...
Read More...
-
![]()
Innovation plans to develop defensin mimetic for Covid-19 treatment
Innovation Pharmaceuticals has announced the consideration of its defensin mimetic drug candidate Brilacidin for the...
Read More...
-
![]()
Coronavirus latest: Deaths pass 2,000; recoveries exceed infections
Deaths from coronavirus Covid-19 have increased to more than 2,000, including 2,004 in mainland China,...
Read More...
-
![]()
WHO says new coronavirus not as deadly as others
World Health Organization (WHO) director-general Dr Tedros Adhanom Ghebreyesus has said the new coronavirus Covid-19...
Read More...
-
![]()
GSK gets US regulatory approval for arthritis pain reliever
GlaxoSmithKline (GSK) has obtained the US Food and Drug Administration (FDA) approval for over-the-counter (OTC)...
Read More...
-
![Beovu]()
EC grants approval to Novartis’ Beovu to treat wet AMD
The European Commission (EC) has approved Novartis’ Beovu (brolucizumab) injection to treat wet age-related macular...
Read More...
-
![]()
China approves first anti-viral drug against coronavirus Covid-19
Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to...
Read More...
-
![]()
Coronavirus Covid-19 deaths increase to 1,873; infections rate drops
The Covid-19 death toll has increased to 1,873, with 98 new deaths in China, as...
Read More...
-
![Merck Ebola vaccine Ervebo]()
Merck’s Ebola vaccine Ervebo available in four African countries
Merck (MSD) has received approval from four African countries for its Ervebo vaccine to prevent...
Read More...
